Company Filing History:
Years Active: 2011
Title: **Jeffery C. Giering: Innovator in RNAi Technology**
Introduction
Jeffery C. Giering, located in Burlingame, California, is a notable inventor known for his contributions to the field of RNA interference (RNAi). With a strong focus on liver-specific therapeutic applications, Giering's innovative work aims to provide new treatment options for various diseases and disorders.
Latest Patents
Giering holds a patent for "RNAi expression constructs with liver-specific enhancer/promoter." This invention offers compositions and methods specifically tailored for RNAi in the liver, which can potentially help in addressing liver-related diseases effectively.
Career Highlights
As a key member of Benitec, Inc., Giering has significantly contributed to the advancement of RNAi technologies. His role in the company exemplifies his commitment to pioneering research that pushes the boundaries of what is possible in gene therapy.
Collaborations
During his career, Giering has worked alongside remarkable colleagues such as Petrus W. Roelvink and David A. Suhy. Their collaborative efforts have fostered an innovative environment, leading to advancements in therapeutic approaches and technologies.
Conclusion
Jeffery C. Giering stands out as a dedicated inventor in the biopharmaceutical industry. His patent contributions highlight the potential for RNAi technologies in treating liver diseases, reinforcing the significance of innovation in medical science. As he continues his work at Benitec, Inc., Giering is poised to make further impactful discoveries in the realm of RNA technology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.